Wall Street analysts expect Monroe Capital Corp (NASDAQ:MRCC) to post sales of $13.35 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Monroe Capital’s earnings, with estimates ranging from $13.07 million to $13.60 million. Monroe Capital reported sales of $11.23 million in the same quarter last year, which would suggest a positive year over year growth rate of 18.9%. The business is scheduled to issue its next earnings results on Tuesday, March 6th.
According to Zacks, analysts expect that Monroe Capital will report full year sales of $13.35 million for the current financial year, with estimates ranging from $50.81 million to $51.30 million. For the next fiscal year, analysts expect that the business will post sales of $60.92 million per share, with estimates ranging from $57.80 million to $64.91 million. Zacks’ sales calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Monroe Capital.
Monroe Capital (NASDAQ:MRCC) last announced its quarterly earnings data on Tuesday, November 7th. The financial services provider reported $0.34 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.34. Monroe Capital had a net margin of 35.62% and a return on equity of 9.47%.
Several hedge funds have recently bought and sold shares of MRCC. Atlantic Trust Group LLC purchased a new position in shares of Monroe Capital in the third quarter valued at $2,056,000. Muzinich & Co. Inc. grew its holdings in shares of Monroe Capital by 18.7% in the second quarter. Muzinich & Co. Inc. now owns 801,138 shares of the financial services provider’s stock valued at $12,201,000 after purchasing an additional 126,196 shares in the last quarter. Sumitomo Mitsui Asset Management Company LTD grew its holdings in shares of Monroe Capital by 14.8% in the third quarter. Sumitomo Mitsui Asset Management Company LTD now owns 462,399 shares of the financial services provider’s stock valued at $6,616,000 after purchasing an additional 59,617 shares in the last quarter. Mckinley Capital Management LLC Delaware grew its holdings in shares of Monroe Capital by 55.2% in the third quarter. Mckinley Capital Management LLC Delaware now owns 127,539 shares of the financial services provider’s stock valued at $1,825,000 after purchasing an additional 45,346 shares in the last quarter. Finally, Chicago Partners Investment Group LLC grew its holdings in shares of Monroe Capital by 29.9% in the third quarter. Chicago Partners Investment Group LLC now owns 128,178 shares of the financial services provider’s stock valued at $1,834,000 after purchasing an additional 29,509 shares in the last quarter. 29.29% of the stock is owned by hedge funds and other institutional investors.
Shares of Monroe Capital (MRCC) opened at $14.11 on Friday. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.52. Monroe Capital has a fifty-two week low of $13.32 and a fifty-two week high of $16.20. The stock has a market cap of $285.59, a P/E ratio of 14.40 and a beta of 0.56.
The firm also recently announced a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Friday, December 15th were issued a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a dividend yield of 9.92%. The ex-dividend date of this dividend was Thursday, December 14th. Monroe Capital’s dividend payout ratio (DPR) is presently 142.86%.
ILLEGAL ACTIVITY NOTICE: This piece was first reported by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/19/13-35-million-in-sales-expected-for-monroe-capital-corp-mrcc-this-quarter.html.
Monroe Capital Company Profile
Monroe Capital Corporation is a closed-end, non-diversified management investment company. The Company is a specialty finance company focused on providing financing primarily to lower middle-market companies in the United States and Canada. The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation primarily through investments in senior, unitranche and junior secured debt, and unsecured subordinated debt and equity.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Monroe Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monroe Capital and related companies with MarketBeat.com's FREE daily email newsletter.